1. Home /
  2. Real Money

Real Money

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists

Jim Cramer and our other experts discuss events that could potentially jolt the market, a stealth trade to consider, and strength in retail.

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists

Jim Cramer and our other experts discuss the FAANG stocks, a market bottom, and potential biotech targets.

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists

Jim Cramer and our other experts tell you what stocks sectors are unaffected by China 'trade war' talk, and as Nike looks ready to move up.

Is Chipotle's Founder Incompetent?

Is Chipotle's Founder Incompetent?

No punches pulled here. Chipotle's Steve Ells still doesn't get it.

Dick's Sporting Goods Issues Weak Guidance

Dick's Sporting Goods Issues Weak Guidance

Shares of Dick's Sporting Goods were lower on Tuesday after issuing weak fourth-quarter guidance.

Finish Line Exploring Alternatives for JackRabbit

Finish Line Exploring Alternatives for JackRabbit

Shares of Finish Line were lower on Tuesday on word it is currently exploring strategic alternatives for the company's specialty running store chain, JackRabbit.

FedEx Downgraded at Stifel

FedEx Downgraded at Stifel

Shares of FedEx were lower on Tuesday after Stifel downgraded the stock to Hold from Buy.

Estee Lauder Buys Too Faced for $1.45 Billion

Estee Lauder Buys Too Faced for $1.45 Billion

Shares of The Estée Lauder Cos. EL were in focus on Tuesday after making its biggest acquisition yet.

Kate Spade Rises, Hedge Fund Urges Co. to Seek Sale

Kate Spade Rises, Hedge Fund Urges Co. to Seek Sale

Caerus Investors urged Kate Spade to seek a sale, sending the stock higher.

Novartis In Talks to Buy Generic Drug Maker

Novartis In Talks to Buy Generic Drug Maker

Novartis is entering into talks to purchase Amneal Pharmaceuticals in a deal that could value the company at $8 billion.